The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Spinal Biologics Market Research Report 2024

Global Spinal Biologics Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763971

No of Pages : 88

Ask Your Query

Synopsis
Global Spinal Biologics market is projected to reach US$ 3906.8 million in 2029, increasing from US$ 2500 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Spinal Biologics market research.

Key manufacturers engaged in the Spinal Biologics industry include Johnson & Johnson (Depuy Synthes), Orthofix Medical, Inc., Stryker Corporation, Zimmer Biomet, Arthrex, Inc., Exactech, Inc., Spine Wave, Inc., Medtronic plc and NuVasive, Inc., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Spinal Biologics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Spinal Biologics market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Spinal Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Johnson & Johnson (Depuy Synthes)
  • Orthofix Medical, Inc.
  • Stryker Corporation
  • Zimmer Biomet
  • Arthrex, Inc.
  • Exactech, Inc.
  • Spine Wave, Inc.
  • Medtronic plc
  • NuVasive, Inc.

Segment by Type

  • Minimally Invasive Surgery
  • Open Surgery

Segment by Application

  • Hospitals
  • Spinal Surgery Centers
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Spinal Biologics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Spinal Biologics Market Overview
1.1 Product Overview and Scope of Spinal Biologics
1.2 Spinal Biologics Segment by Type
1.2.1 Global Spinal Biologics Market Value Comparison by Type (2023-2029)
1.2.2 Minimally Invasive Surgery
1.2.3 Open Surgery
1.3 Spinal Biologics Segment by Application
1.3.1 Global Spinal Biologics Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Spinal Surgery Centers
1.3.4 Others
1.4 Global Spinal Biologics Market Size Estimates and Forecasts
1.4.1 Global Spinal Biologics Revenue 2018-2029
1.4.2 Global Spinal Biologics Sales 2018-2029
1.4.3 Global Spinal Biologics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Spinal Biologics Market Competition by Manufacturers
2.1 Global Spinal Biologics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Spinal Biologics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Spinal Biologics Average Price by Manufacturers (2018-2023)
2.4 Global Spinal Biologics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Spinal Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Spinal Biologics, Product Type & Application
2.7 Spinal Biologics Market Competitive Situation and Trends
2.7.1 Spinal Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Spinal Biologics Players Market Share by Revenue
2.7.3 Global Spinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Spinal Biologics Retrospective Market Scenario by Region
3.1 Global Spinal Biologics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Spinal Biologics Global Spinal Biologics Sales by Region: 2018-2029
3.2.1 Global Spinal Biologics Sales by Region: 2018-2023
3.2.2 Global Spinal Biologics Sales by Region: 2024-2029
3.3 Global Spinal Biologics Global Spinal Biologics Revenue by Region: 2018-2029
3.3.1 Global Spinal Biologics Revenue by Region: 2018-2023
3.3.2 Global Spinal Biologics Revenue by Region: 2024-2029
3.4 North America Spinal Biologics Market Facts & Figures by Country
3.4.1 North America Spinal Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Spinal Biologics Sales by Country (2018-2029)
3.4.3 North America Spinal Biologics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Spinal Biologics Market Facts & Figures by Country
3.5.1 Europe Spinal Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Spinal Biologics Sales by Country (2018-2029)
3.5.3 Europe Spinal Biologics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Spinal Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Spinal Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Spinal Biologics Sales by Country (2018-2029)
3.6.3 Asia Pacific Spinal Biologics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Spinal Biologics Market Facts & Figures by Country
3.7.1 Latin America Spinal Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Spinal Biologics Sales by Country (2018-2029)
3.7.3 Latin America Spinal Biologics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Spinal Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Spinal Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Spinal Biologics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Spinal Biologics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Spinal Biologics Sales by Type (2018-2029)
4.1.1 Global Spinal Biologics Sales by Type (2018-2023)
4.1.2 Global Spinal Biologics Sales by Type (2024-2029)
4.1.3 Global Spinal Biologics Sales Market Share by Type (2018-2029)
4.2 Global Spinal Biologics Revenue by Type (2018-2029)
4.2.1 Global Spinal Biologics Revenue by Type (2018-2023)
4.2.2 Global Spinal Biologics Revenue by Type (2024-2029)
4.2.3 Global Spinal Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Spinal Biologics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Spinal Biologics Sales by Application (2018-2029)
5.1.1 Global Spinal Biologics Sales by Application (2018-2023)
5.1.2 Global Spinal Biologics Sales by Application (2024-2029)
5.1.3 Global Spinal Biologics Sales Market Share by Application (2018-2029)
5.2 Global Spinal Biologics Revenue by Application (2018-2029)
5.2.1 Global Spinal Biologics Revenue by Application (2018-2023)
5.2.2 Global Spinal Biologics Revenue by Application (2024-2029)
5.2.3 Global Spinal Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Spinal Biologics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson (Depuy Synthes)
6.1.1 Johnson & Johnson (Depuy Synthes) Corporation Information
6.1.2 Johnson & Johnson (Depuy Synthes) Description and Business Overview
6.1.3 Johnson & Johnson (Depuy Synthes) Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson (Depuy Synthes) Spinal Biologics Product Portfolio
6.1.5 Johnson & Johnson (Depuy Synthes) Recent Developments/Updates
6.2 Orthofix Medical, Inc.
6.2.1 Orthofix Medical, Inc. Corporation Information
6.2.2 Orthofix Medical, Inc. Description and Business Overview
6.2.3 Orthofix Medical, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Orthofix Medical, Inc. Spinal Biologics Product Portfolio
6.2.5 Orthofix Medical, Inc. Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Corporation Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Stryker Corporation Spinal Biologics Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Spinal Biologics Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Arthrex, Inc.
6.5.1 Arthrex, Inc. Corporation Information
6.5.2 Arthrex, Inc. Description and Business Overview
6.5.3 Arthrex, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arthrex, Inc. Spinal Biologics Product Portfolio
6.5.5 Arthrex, Inc. Recent Developments/Updates
6.6 Exactech, Inc.
6.6.1 Exactech, Inc. Corporation Information
6.6.2 Exactech, Inc. Description and Business Overview
6.6.3 Exactech, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Exactech, Inc. Spinal Biologics Product Portfolio
6.6.5 Exactech, Inc. Recent Developments/Updates
6.7 Spine Wave, Inc.
6.6.1 Spine Wave, Inc. Corporation Information
6.6.2 Spine Wave, Inc. Description and Business Overview
6.6.3 Spine Wave, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Spine Wave, Inc. Spinal Biologics Product Portfolio
6.7.5 Spine Wave, Inc. Recent Developments/Updates
6.8 Medtronic plc
6.8.1 Medtronic plc Corporation Information
6.8.2 Medtronic plc Description and Business Overview
6.8.3 Medtronic plc Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medtronic plc Spinal Biologics Product Portfolio
6.8.5 Medtronic plc Recent Developments/Updates
6.9 NuVasive, Inc.
6.9.1 NuVasive, Inc. Corporation Information
6.9.2 NuVasive, Inc. Description and Business Overview
6.9.3 NuVasive, Inc. Spinal Biologics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 NuVasive, Inc. Spinal Biologics Product Portfolio
6.9.5 NuVasive, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Spinal Biologics Industry Chain Analysis
7.2 Spinal Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Spinal Biologics Production Mode & Process
7.4 Spinal Biologics Sales and Marketing
7.4.1 Spinal Biologics Sales Channels
7.4.2 Spinal Biologics Distributors
7.5 Spinal Biologics Customers
8 Spinal Biologics Market Dynamics
8.1 Spinal Biologics Industry Trends
8.2 Spinal Biologics Market Drivers
8.3 Spinal Biologics Market Challenges
8.4 Spinal Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock